Historique
Article de Périodique
Efficacy of heroin-assisted treatment in Belgium: A randomised controlled trial (2015)
Auteur(s) :
DEMARET, I. ;
QUERTEMONT, E. ;
LITRAN, G. ;
MAGOGA, C. ;
DEBLIRE, C. ;
DUBOIS, N. ;
DE ROUBAIX, J. ;
CHARLIER, C. ;
LEMAITRE, A. ;
ANSSEAU, M.
Année
2015
Page(s) :
179-187
Langue(s) :
Anglais
Refs biblio. :
39
Domaine :
Drogues illicites / Illicit drugs
Thésaurus géographique
BELGIQUE
Thésaurus mots-clés
ETUDE CLINIQUE
;
ETUDE RANDOMISEE
;
EFFICACITE
;
HEROINE
;
DISTRIBUTION CONTROLEE
;
TRAITEMENT DE MAINTENANCE
Résumé :
Background/Aims: Heroin-assisted treatment (HAT) can improve the condition of heroin addicts still using street heroin after a methadone treatment. In Belgium, a new trial compared the efficacy of a HAT to existing methadone maintenance treatment.
Methods: In this randomised controlled trial, HAT was limited to 12 months. Participants were assessed every 3 months. They were responders if they showed improvement on the level of street heroin use, health or criminal involvement.
Results: 74 participants were randomised in the trial. The experimental group (n = 36) counted 30% of responders more than the control group (n = 38) at each assessment point (p < 0.05), except at 12 months where the difference (11%) was no longer significant (p = 0.35). Still, after 12 months, participants in the experimental group reported significantly greater improvements (p < 0.05) than the control group on the level of street heroin use and on the level of physical and mental health. Both groups reported significantly less criminal acts after 12 months (p < 0.001), but with no significant difference between the groups.
Conclusions: This trial confirms the short-term efficacy of HAT for severe heroin addicts, who already failed methadone treatment. (C) 2015 S. Karger AG, Basel
Methods: In this randomised controlled trial, HAT was limited to 12 months. Participants were assessed every 3 months. They were responders if they showed improvement on the level of street heroin use, health or criminal involvement.
Results: 74 participants were randomised in the trial. The experimental group (n = 36) counted 30% of responders more than the control group (n = 38) at each assessment point (p < 0.05), except at 12 months where the difference (11%) was no longer significant (p = 0.35). Still, after 12 months, participants in the experimental group reported significantly greater improvements (p < 0.05) than the control group on the level of street heroin use and on the level of physical and mental health. Both groups reported significantly less criminal acts after 12 months (p < 0.001), but with no significant difference between the groups.
Conclusions: This trial confirms the short-term efficacy of HAT for severe heroin addicts, who already failed methadone treatment. (C) 2015 S. Karger AG, Basel
Affiliation :
Institut des Sciences Humaines et Sociales, Université de Liège, Belgium
Cote :
Abonnement